Work

Survival outcomes for ovarian cancer patients in the post–poly ADP-ribose polymerase inhibitor (PARPi) era in the US.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.5586

Authors: Henry Becerra, Oboseh John Ogedegbe, Angela Green

Institutions: Brookdale University Hospital and Medical Center, Trinity Health Ann Arbor Hospital, Memorial Sloan Kettering Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812953

Cites:

Cited by:

Related to: 10